Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant.

[1]  P. Religa,et al.  Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Joh,et al.  Is cytomegalovirus infection dangerous in cytomegalovirus‐seropositive recipients after liver transplantation? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  M. Zembala,et al.  Cytomegalovirus infection does not accelerate microvasculopathy development in heart transplant recipients. , 2009, Transplantation proceedings.

[4]  O. Hes,et al.  Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis , 2009, Transplantation.

[5]  V. Kliem,et al.  Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  H. Rollag,et al.  Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk , 2007, Clinical Transplantation.

[7]  V. Emery,et al.  Cytomegalovirus in transplantation – challenging the status quo , 2007, Clinical transplantation.

[8]  C. Marroni,et al.  Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation. , 2006, Transplantation proceedings.

[9]  L. Folgueira,et al.  Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. , 2005, Transplantation proceedings.

[10]  A. Limaye,et al.  Late-Onset Cytomegalovirus Disease in Liver Transplant Recipients Despite Antiviral Prophylaxis1 , 2004, Transplantation.

[11]  H. Rollag,et al.  Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. , 2004, Kidney international.

[12]  I. Gich,et al.  Significance of cytomegalovirus infection in renal transplantation. , 2003, Transplantation proceedings.

[13]  A. Branzi,et al.  Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study , 2003, Transplantation.

[14]  P. Griffiths,et al.  Definitions of cytomegalovirus infection and disease in transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  B. Kasiske,et al.  Cytomegalovirus disease is not a major risk factor for ischemic heart disease after renal transplantation. , 2001, Transplantation.

[16]  P. Schafer,et al.  Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients. , 2001 .

[17]  M. Mihatsch,et al.  CYTOMEGALOVIRUS INFECTION AND GRAFT REJECTION IN RENAL TRANSPLANTATION , 2001, Transplantation.

[18]  L. Schaade,et al.  Detection of Cytomegalovirus DNA in Human Specimens by LightCycler PCR , 2000, Journal of Clinical Microbiology.

[19]  D. Dunn,et al.  Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. , 1999, Transplantation.

[20]  J. Wingard.  Opportunistic infections after blood and marrow transplantation , 1999, Transplant infectious disease : an official journal of the Transplantation Society.

[21]  R. Rubin.  Importance of CMV in the transplant population. , 1999, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  C. Payá.  Indirect effects of CMV in the solid organ transplant patient. , 1999, Transplant infectious disease : an official journal of the Transplantation Society.

[23]  R. Wiesner,et al.  Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. , 1998, Transplantation.

[24]  J. Gavaldà,et al.  Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  G. Tufveson,et al.  A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival. , 1996, Clinical transplantation.

[26]  V. Starnes,et al.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.

[27]  H. Balfour,et al.  CYTOMEGALOVIRUS AS A RISK FACTOR IN RENAL TRANSPLANTATION , 1980, Transplantation.